@article{e50d2702cb334ada9c78e6ae73fd3c09,
title = "The search for treatments for veterans with major depression: Of paramount importance, yet still elusive",
author = "Nemeroff, {Charles B.}",
note = "Funding Information: reports receiving research support or grants from the National Institutes of Health, and Stanley Medical Research Institute; receiving consulting fees from Xhale, Takeda, Taisho Pharmaceutical Inc, Bracket (Clintara), Fortress Biotech, Sunovion Pharmaceuticals Inc, Janssen Research and Development LLC, Magstim Inc, Navitor Pharmaceuticals Inc, TC MSO Inc, and Intra-Cellular Therapies, Inc; holding stock in Xhale, Celgene, Seattle Genetics, Abbvie, OPKO Health Inc, Antares, BI Gen Holdings Inc, Corcept Therapeutics Pharmaceuticals Company, and Gilead; acting as a member of scientific advisory boards for the American Foundation for Suicide Prevention, Brain and Behavior Research Foundation, Xhale, Anxiety Disorders Association of America, Skyland Trail, Bracket, and Laureate Institute for Brain Research, Inc; serving on the board of directors of American Foundation for Suicide Prevention, Gratitude America, and Anxiety Disorders Association of America; and having income or equity of $10 000 or more from American Psychiatric Publishing, Xhale, Bracket (Clintara), CME Outfitters, Takeda, Intra-Cellular Therapies Inc, and Magstim. He also holds patents in the Method and devices for transdermal delivery of lithium (US 6,375,990B1) and the Method of assessing antidepressant drug therapy via transport inhibition of monoamine neurotransmitters by ex vivo assay (US 7,148,027B2). No other disclosures were reported. Copyright: Copyright 2018 Elsevier B.V., All rights reserved.",
year = "2018",
month = sep,
doi = "10.1001/jamapsychiatry.2018.1591",
language = "English (US)",
volume = "75",
pages = "877--878",
journal = "JAMA Psychiatry",
issn = "2168-622X",
publisher = "American Medical Association",
number = "9",
}
